Doctor profile · Federal record
Dr. Peter Dipasco, MD
Surgical Oncology Physician (CMS: Surgical Oncology) · Surgical Oncology Physician · Surgical Oncology Physician · Saint Louis, MO
- NPI 1659491314
- Accepts Medicare
- 22 yrs in practice
- Licensed in 3 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
10050 Kennerly RD Ste 2500
Saint Louis, MO 631282195
(314) 525-4440
fax (314) 525-4531
Credentials & registration
- NPI registered
- March 2007 — 19 yrs on file
- Profile last updated
- November 26, 2024
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 2086X0206X — NUCC code
- State licenses (3)
- Missouri #2020036303 · Kansas #04-34718 · Florida #ME 111387
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1659491314. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
119
Distinct HCPCS
4
Medicare allowed
$31,517
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99205 |
New patient office or other outpatient visit, 60-74 minutes | 67 | 67 | $212 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 26 | 24 | $89 | |
60500 |
Removal or exploration of parathyroid glands | 14 | 14 | $918 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 12 | 11 | $177 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 39. This provider delivers 3.1× the peer median.Open Payments
Industry payments received
All-time total
$64,549
Transactions
51
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Ethicon US, LLC | 7 | $35,613.22 | |
| Medical Device Business Services, Inc. | 10 | $21,222.49 | |
| Ethicon Endo-Surgery Inc. | 2 | $5,258.00 | |
| HISTOSONICS,INC. | 5 | $938.96 | |
| Tempus AI, Inc | 3 | $251.10 | |
| Hologic Sales and Service, LLC | 2 | $195.36 | |
| Intera Oncology, Inc | 1 | $175.02 | |
| Stryker Corporation | 1 | $173.18 | |
| Janssen Biotech, Inc. | 5 | $90.23 | |
| Merck Sharp & Dohme LLC | 3 | $81.52 | |
| PFIZER INC. | 3 | $77.18 | |
| AstraZeneca Pharmaceuticals LP | 3 | $61.97 | |
| Daiichi Sankyo Inc. | 2 | $52.40 | |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36.47 | |
| Novartis Pharmaceuticals Corporation | 2 | $32.39 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
32
Patients
19
Total drug cost
$201
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Oxycodone Hcl | Generic | 20 | 19 | $133 |
| Levothyroxine Sodium | Generic | 12 | 0 | $68 |
Hospital affiliations
Frequently asked questions
What is Dr. Peter Dipasco's medical specialty?
Dr. Peter Dipasco practices Surgical Oncology Physician in Saint Louis, MO.
Where does Dr. Peter Dipasco practice?
Dr. Peter Dipasco practices at 10050 Kennerly RD Ste 2500, Saint Louis, MO 631282195. Office phone: 3145254440.
What is Dr. Peter Dipasco's NPI?
Dr. Peter Dipasco's National Provider Identifier (NPI) is 1659491314, issued by NPPES.
Does Dr. Peter Dipasco accept Medicare assignment?
Yes. Dr. Peter Dipasco accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Peter Dipasco commonly perform?
Top Medicare-reported procedures in 2023: New patient office or other outpatient visit (HCPCS 99205); Established patient office or other outpatient visit (HCPCS 99213); Removal or exploration of parathyroid glands (HCPCS 60500). Source: CMS Medicare Physician & Other Practitioners file.